Catalyst Wire Dossier Catalyst Wire Dossier

MVA HIV multiantigen vaccine

recombinant Modified Vaccinia Ankara HIV multiantigen vaccine · Bavarian Nordic
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MVA HIV multiantigen vaccine, covering 2010-05-20 to 2010-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Phase I Safety Study of a Recombinant MVA HIV Multiantigen Vaccine in HIV-infected Subjects [Phase 1]

See pricing